Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001244048 | SCV001417242 | uncertain significance | Severe combined immunodeficiency due to DCLRE1C deficiency | 2022-08-22 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 543 of the DCLRE1C protein (p.Ile543Val). This variant is present in population databases (rs777250271, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with DCLRE1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 968823). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002480821 | SCV002791463 | uncertain significance | Severe combined immunodeficiency due to DCLRE1C deficiency; Histiocytic medullary reticulosis | 2021-07-23 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001277653 | SCV001464617 | uncertain significance | Histiocytic medullary reticulosis | 2020-04-11 | no assertion criteria provided | clinical testing |